For products that have not yet been on the market for five full years (Wegovy, Mounjaro, and Zepbound), revenue projections are based on Wall Street consensus estimates as of 12/15/2024
GLP-1 receptor agonists in gastrointestinal practices: enhancing both procedural and patient-related outcomes
The body defends its previous weight through hormonal and metabolic mechanisms that persist even after weight loss
Older patients typically have lower baseline collagen and may notice changes more quickly
Maeta A, Sano M, Fukuwatari T, et al Simultaneous measurement of nicotinamide and its catabolites, nicotinamide Noxide, N(1)methyl2pyridone5carboxamide, and N(1)methyl4pyridone3carboxamide, in mice urine
And for good reason, the science behind them is solid, and the results can be dramatic